Expert consensus protocol on colistin resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
This expert consensus protocol for colistin resistance detection and characterisation was jointly developed by the EURGenCCRE consortium, the scientific advisory board for EURGen-Net and ECDC to agree upon the best available strategy for phenotypic and genotypic colistin-resistance detection and confirmation to be used for the CCRE survey. A separate expert consensus protocol was also developed for carbapenem resistance detection and characterisation, as well as a laboratory manual with detailed methodological information for characterisation of CCRE isolates.
The primary objective of the CCRE survey is to determine the occurrence, geographic distribution and population dynamics within healthcare settings of high-risk CCRE clones, and/or transmissible resistance/genetic elements of critical public health importance in Europe, in order to enable informed risk assessment and control policies.
Expert consensus protocol on carbapenem resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
This expert consensus protocol for carbapenem resistance detection and characterisation was jointly developed by the EURGenCCRE consortium, the scientific advisory board for EURGen-Net and ECDC to agree upon the protocol for phenotypic and genotypic carbapenem resistance detection and confirmation to be used for the CCRE survey.
See more protocols related to antimicrobial resistance
More on the topic
Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: Guidance from the European Centre for Disease Prevention and ControlRead more
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
7 Jun 2018 - This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level
23 Jul 2018 - This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae.
ECDC calls for continued action to address antimicrobial resistance in healthcare settings
15 Nov 2018 - On European Antibiotic Awareness Day, ECDC publishes the results of two point-prevalence surveys of healthcare-associated infections and antimicrobial use in hospitals and in long-term care facilities in the EU/EEA.
33000 people die every year due to infections with antibiotic-resistant bacteria
6 Nov 2018 - An ECDC study estimates the burden of five types of infections caused by antibiotic-resistant bacteria of public health concern in the European Union and in the European Economic Area (EU/EEA).
European Antibiotic Awareness Day Campaign Website
European Antibiotic Awareness Day (EAAD) is a European health initiative coordinated by ECDC, which provides a platform and support for national campaigns on the prudent use of antibiotics. Each year, EAAD is marked on 18 November. Visit the campaign website of EAAD.Read more